Jasper Health, LLS collaborate to support blood cancer patients

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jasper Health, a virtual cancer care navigation and supportive care solution, is collaborating with  The Leukemia & Lymphoma Society to provide comprehensive support and resources to blood cancer patients and their caregivers.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Positive high-level results from an interim analysis of the AMPLIFY phase III trial showed a fixed duration of Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, demonstrated a statistically significant and clinically meaningful improvement in progression-free survival compared to standard-of-care chemoimmunotherapy in previously untreated adult patients with chronic lymphocytic leukemia.

Login